• OncologyTube
    • 0
      • Title
        User LIVE NOW
      • LIVE NOW
        Title
        User
        • Sign In
    • Home
    • Trending

    • Sign In

    • Audios and Videos
    • Videos
    • Audios

    • Channels

    • Browse Channels

    • Categories

    • Acute Lymphoblastic Leukemia 5635
    • Acute Myelogenous Leukemia 148
    • Bladder Cancer 49
    • Bone Metastases 1
    • Brain Cancer 16
    • Breast Cancer 120
    • Business Management 2
    • Cervical Cancer 2
    • Chronic Lymphocytic Leukemia 147
    • Chronic Myelogenous Leukemia 16
    • Colorectal Cancer 75
    • Gastrointestinal Cancer 70
    • General 243
    • Head and Neck Cancers 34
    • Hematologic Malignancies 79
    • Hodgkin Lymphoma 18
    • Immunotherapy 83
    • Kidney Cancer 364
    • Liver Cancer 11
    • Lymphoma 145
    • Melanoma and Skin Cancer 51
    • Multiple Myeloma 332
    • Myeloproliferative Disease 15
    • News 110
    • Non-Hodgkin Lymphoma 43
    • Non-Small Cell Lung Cancer 267
    • Other 110
    • Ovarian Cancer 10
    • Pancreatic Cancer 54
    • Patient Resources 27
    • Prostate Cancer 148
    • Small Cell Lung Cancer 58
    • Soft Tissue Sarcoma 9
    • Supportive Care 38
    • Testicular Cancer 2
    • Urology 6
    • Uterine Cancer 2

    • About
    • Contact
    Mohamad Mohty on EBMT 2016
    00:03:01

    Mohamad Mohty on EBMT 2016

    Mohamad Mohty, MD, PhD, from Saint-Antoine Hospital, Paris, France and President of the European Society for Blood and Marrow Transplantation (EBMT), provides an overview of the sessions and themes of the 42nd Annual Meeting of the EBMT held in Valencia, Spain. The range of topics covered this year include standard and novel therapies as well as the use of stem cell transplantation for diseases such as leukemia, lymphoma and veno-occlusive disease (VOD). Prof. Mohty also talks about the novel features and innovations in the structure of the meeting, such as a session on social media and its importance for clinicians. This year, patients have been involved in the meeting and speaking in some of the sessions. Furthermore, during the session on the partnership between Pharma and Academia, stakeholders from both sides will come together to discuss how they can unite their energies, to work towards the goal of curing these diseases.

    Acute Lymphoblastic Leukemia
    392 Views
    3 years ago
    VJHemOnc
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Live

    Trending

    Next steps for niraparib for ovarian cancer following on from the ENGOT-OV16/NOVA trial
    00:01:13

    Next steps for niraparib for ovarian cancer following on from the ENGOT-OV16/NOVA trial

    Acute Lymphoblastic Leukemia
    783 Views
    3 years ago
    VJOncology
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Lacking Data In Current Kidney Cancer Landscape | May Extrapolate Previous Retrospective Data
    00:01:20

    Lacking Data In Current Kidney Cancer Landscape | May Extrapolate Previous Retrospective Data

    Kidney Cancer
    54 Views
    1 year ago
    Annual-Meeting
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Development and application of virus-specific T cells
    00:02:57

    Development and application of virus-specific T cells

    Acute Lymphoblastic Leukemia
    354 Views
    3 years ago
    VJHemOnc
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    The BCR signaling pathway
    00:22:22

    The BCR signaling pathway

    Acute Lymphoblastic Leukemia
    929 Views
    2 years ago
    imedex
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Outcomes Of The ECHELON-2 Study
    00:03:11

    Outcomes Of The ECHELON-2 Study

    Acute Lymphoblastic Leukemia
    52 Views
    10 months ago
    obr
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Treating CLL-Related Fatigue
    00:06:13

    Treating CLL-Related Fatigue

    Acute Lymphoblastic Leukemia
    300 Views
    3 years ago
    P2Professional
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    What causes mechanism resistance to Rociletinib and AZD9291?
    00:01:26

    What causes mechanism resistance to Rociletinib and AZD9291?

    Acute Lymphoblastic Leukemia
    352 Views
    4 years ago
    lung
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Cabozantinib for advanced renal cell carcinoma: the METEOR and CABOSUN trials
    00:01:11

    Cabozantinib for advanced renal cell carcinoma: the METEOR and CABOSUN trials

    Acute Lymphoblastic Leukemia
    903 Views
    3 years ago
    VJOncology
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Managing 2nd And 3rd Line mCRC Patients
    00:02:13

    Managing 2nd And 3rd Line mCRC Patients

    Colorectal Cancer
    64 Views
    10 months ago
    obr
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    MRD Testing: Primary Endpoint For Drug Development
    00:01:37

    MRD Testing: Primary Endpoint For Drug Development

    Multiple Myeloma
    69 Views
    11 months ago
    imedex
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Epigenetics and Immunotherapy: Confusing Cancer Cells
    00:04:17

    Epigenetics and Immunotherapy: Confusing Cancer Cells

    Acute Lymphoblastic Leukemia
    330 Views
    3 years ago
    P2Professional
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Analyzing cancer imaging data from few datasets
    00:00:49

    Analyzing cancer imaging data from few datasets

    Acute Lymphoblastic Leukemia
    133 Views
    1 year ago
    VJOncology
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Latest Videos

    Caris Life Sciences and Ambry Genetics Partner to Advance Cancer Care

    Caris Life Sciences and Ambry Genetics Partner to Advance Cancer Care

    News
    2 Views
    1 day ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Long-Term Results from Phase 3 ALTA-1L Trial Long-Term Results from Phase 3 ALTA-1L Trial
    0:04:29

    Long-Term Results from Phase 3 ALTA-1L Trial

    Non-Small Cell Lung Cancer
    26 Views
    2 days ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Mount Sinai Receives $1 Million Grant for Prostate Cancer Research

    Mount Sinai Receives $1 Million Grant for Prostate Cancer Research

    News
    2 Views
    2 days ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Treatment-Free Survival, With and Without Toxicity Treatment-Free Survival, With and Without Toxicity
    0:05:48

    Treatment-Free Survival, With and Without Toxicity

    Kidney Cancer
    10 Views
    2 days ago
    kidneycancer
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1 Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
    0:02:51

    Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1

    Kidney Cancer
    1 Views
    2 days ago
    kidneycancer
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    What's To Come in Modern Imaging Technology What's To Come in Modern Imaging Technology
    0:03:54

    What's To Come in Modern Imaging Technology

    Kidney Cancer
    4 Views
    3 days ago
    kidneycancer
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Acute Lymphoblastic Leukemia

    Phase 1/2 AUGMENT-101 Trial @sloan_kettering Phase 1/2 AUGMENT-101 Trial @sloan_kettering
    0:04:52

    Phase 1/2 AUGMENT-101 Trial @sloan_kettering

    12 Views
    2 weeks ago
    Memorial Sloan Kettering
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Melanoma Rates Decline Found in Younger Population Melanoma Rates Decline Found in Younger Population
    0:03:21

    Melanoma Rates Decline Found in Younger Population

    2 Views
    3 weeks ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Syndax Announces First Patient Dosed in Phase 1/2 AUGMENT-101 Trial of SNDX-5613 for the Treatment of Adults with Relapsed/Refractory Acute Leukemias

    Syndax Announces First Patient Dosed in Phase 1/2 AUGMENT-101 Trial of SNDX-5613 for the Treatment of Adults with Relapsed/Refractory Acute Leukemias

    12 Views
    1 month ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    What is PFS2 in Advanced NSCLC, and Should we Care_ Unique Analysis of the KEYNOTE-024 trial [720p] - OncologyTube
    EE:EE:EE

    What is PFS2 in Advanced NSCLC, and Should we Care_ Unique Analysis of the KEYNOTE-024 trial [720p] - OncologyTube

    38 Views
    2 months ago
    Stan
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Patient Priorities Should be Paramount when Measuring Quality in Cancer Care According to Panelists at NCCN Policy Summit

    Patient Priorities Should be Paramount when Measuring Quality in Cancer Care According to Panelists at NCCN Policy Summit

    22 Views
    2 months ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    IASLC World Conference on Lung Cancer—Press Briefing Summary from Sunday, September 8th in Barcelona

    IASLC World Conference on Lung Cancer—Press Briefing Summary from Sunday, September 8th in Barcelona

    32 Views
    2 months ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Acute Myelogenous Leukemia

    Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia

    Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia

    5 Views
    3 days ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Actinium Announces Positive Interim Results from Iomab-B Pivotal Phase 3 SIERRA Trial at 50% of Total Patient Enrollment

    Actinium Announces Positive Interim Results from Iomab-B Pivotal Phase 3 SIERRA Trial at 50% of Total Patient Enrollment

    15 Views
    1 month ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    How to Manage MDS Patients who are Ineligible for Transplant
    00:01:47

    How to Manage MDS Patients who are Ineligible for Transplant

    300 Views
    5 months ago
    obr
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    The Recent Wave of Approval in AML
    00:01:54

    The Recent Wave of Approval in AML

    138 Views
    5 months ago
    obr
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Updated Data on Gilteritinib in AML
    00:01:12

    Updated Data on Gilteritinib in AML

    16 Views
    5 months ago
    obr
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Latest Data on Uproleselan with Chemotherapy
    00:01:16

    Latest Data on Uproleselan with Chemotherapy

    100 Views
    5 months ago
    obr
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Bladder Cancer

    EV-103: Enfortumab Vedotin plus Pembrolizumab #ESMO19 EV-103: Enfortumab Vedotin plus Pembrolizumab #ESMO19
    0:02:13

    EV-103: Enfortumab Vedotin plus Pembrolizumab #ESMO19

    16 Views
    1 month ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    EV-103 Phase I Trial Presented at #ESMO19 EV-103 Phase I Trial Presented at #ESMO19
    0:01:45

    EV-103 Phase I Trial Presented at #ESMO19

    22 Views
    1 month ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Seattle Genetics and Astellas Announce US FDA Grants Priority Review for Enfortumab Vedotin Biologics License Application in Locally Advanced or Metastatic Urothelial Cancer

    Seattle Genetics and Astellas Announce US FDA Grants Priority Review for Enfortumab Vedotin Biologics License Application in Locally Advanced or Metastatic Urothelial Cancer

    33 Views
    2 months ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Mount Sinai Receives $1.7 million to Study Natural Killer Cell Dysfunction in Bladder Cancer

    Mount Sinai Receives $1.7 million to Study Natural Killer Cell Dysfunction in Bladder Cancer

    23 Views
    2 months ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Strategies for Treating 2nd Line RCC Patients
    00:01:17

    Strategies for Treating 2nd Line RCC Patients

    54 Views
    5 months ago
    obr
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Treating Newly Diagnosed RCC Patients
    00:02:08

    Treating Newly Diagnosed RCC Patients

    53 Views
    5 months ago
    obr
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Bone Metastases

    If Practitioner Identifies Light-Chain Amyloidosis | Referring to Site Where Trial is Open is a Great Idea
    00:00:40

    If Practitioner Identifies Light-Chain Amyloidosis | Referring to Site Where Trial is Open is a Great Idea

    194 Views
    1 year ago
    Annual-Meeting
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Brain Cancer

    Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published

    Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published

    4 Views
    2 weeks ago
    alexvarney
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Predicting Tumor Recurrence: How Does This Help Us? Predicting Tumor Recurrence: How Does This Help Us?
    0:03:05

    Predicting Tumor Recurrence: How Does This Help Us?

    7 Views
    1 month ago
    Baylor College of Medicine
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Predicting Tumor Recurrence Predicting Tumor Recurrence
    0:03:36

    Predicting Tumor Recurrence

    19 Views
    1 month ago
    Baylor College of Medicine
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    How does this affect clinicians today? How does this affect clinicians today?
    0:01:20

    How does this affect clinicians today?

    7 Views
    2 months ago
    Cleveland Clinic
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Targeting Metabolic Reprogramming to Radiosensitize Glioblastoma Stem Cells Targeting Metabolic Reprogramming to Radiosensitize Glioblastoma Stem Cells
    0:01:26

    Targeting Metabolic Reprogramming to Radiosensitize Glioblastoma Stem Cells

    15 Views
    2 months ago
    Cleveland Clinic
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Oncoceutics Commemorates National Childhood Cancer Awareness Month

    Oncoceutics Commemorates National Childhood Cancer Awareness Month

    14 Views
    2 months ago
    alexvarney
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Breast Cancer

    CytoDyn Reports Early Results from First Patient in its Phase 1b/2 CCR5+ Metastatic Triple-Negative Breast Cancer Trial

    CytoDyn Reports Early Results from First Patient in its Phase 1b/2 CCR5+ Metastatic Triple-Negative Breast Cancer Trial

    6 Views
    3 days ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Is This Going To Affect Survival? @DukeCancer @DrLolaFayanju Is This Going To Affect Survival? @DukeCancer @DrLolaFayanju
    0:03:14

    Is This Going To Affect Survival? @DukeCancer @DrLolaFayanju

    1 Views
    5 days ago
    Duke Cancer
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Radiation After Breast Cancer Diagnosis @DukeCancer @DrLolaFayanju Radiation After Breast Cancer Diagnosis @DukeCancer @DrLolaFayanju
    0:02:49

    Radiation After Breast Cancer Diagnosis @DukeCancer @DrLolaFayanju

    4 Views
    5 days ago
    Duke Cancer
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Who is Eligible for the AVIATOR Study? @SeattleCCA Who is Eligible for the AVIATOR Study? @SeattleCCA
    0:02:08

    Who is Eligible for the AVIATOR Study? @SeattleCCA

    2 Views
    3 weeks ago
    SeattleCCA
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    The AVIATOR Study @SeattleCCA The AVIATOR Study @SeattleCCA
    0:04:33

    The AVIATOR Study @SeattleCCA

    3 Views
    3 weeks ago
    SeattleCCA
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Roswell Park Breast Surgery Chief Gives Keynote Talk on Immunotherapy for Breast Cancer

    Roswell Park Breast Surgery Chief Gives Keynote Talk on Immunotherapy for Breast Cancer

    8 Views
    1 month ago
    Roswell Park
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Business Management

    Two Sided Payment Agreements & The Risks Involved
    00:01:47

    Two Sided Payment Agreements & The Risks Involved

    116 Views
    10 months ago
    obr
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    MOASC COAnalyzer Tool Ricky Newton
    01:01:00

    MOASC COAnalyzer Tool Ricky Newton

    99 Views
    1 year ago
    moasc
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Cervical Cancer

    Novel revelations in CLL biology with venetoclax/ibrutinib
    00:02:24

    Novel revelations in CLL biology with venetoclax/ibrutinib

    93 Views
    1 year ago
    VJHemOnc
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Immunotherapy in gynecological cancers: current and future landscape
    00:02:35

    Immunotherapy in gynecological cancers: current and future landscape

    474 Views
    1 year ago
    VJOncology
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Chronic Lymphocytic Leukemia

    Phase 3 DUO Study @ospniguarda Phase 3 DUO Study @ospniguarda
    0:11:36

    Phase 3 DUO Study @ospniguarda

    9 Views
    2 weeks ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    ASH 2016 Page 3 Maintenance Therapy in Chronic Lymphocytic Leukemia
    00:04:47

    ASH 2016 Page 3 Maintenance Therapy in Chronic Lymphocytic Leukemia

    201 Views
    5 months ago
    cancergrace
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    ASH 2016 Page 2 Update on New Chronic Lymphocytic Leukemia Drugs
    00:07:04

    ASH 2016 Page 2 Update on New Chronic Lymphocytic Leukemia Drugs

    92 Views
    5 months ago
    cancergrace
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    CLL, What is the significance of IGHV mutations and how are they assessed
    00:02:48

    CLL, What is the significance of IGHV mutations and how are they assessed

    87 Views
    5 months ago
    cancergrace
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Not Your Fathers CLL with Dr. John Pagel
    01:02:14

    Not Your Fathers CLL with Dr. John Pagel

    114 Views
    5 months ago
    cancergrace
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    CLL, Is there a role still for chemo AND who should get chemo
    00:04:01

    CLL, Is there a role still for chemo AND who should get chemo

    75 Views
    5 months ago
    cancergrace
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Chronic Myelogenous Leukemia

    Treating CML & Myelofibrosis Patients
    00:01:34

    Treating CML & Myelofibrosis Patients

    319 Views
    11 months ago
    imedex
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Resistance/intolerance to second generation TKIs in CML: what to do next?
    00:02:14

    Resistance/intolerance to second generation TKIs in CML: what to do next?

    155 Views
    1 year ago
    VJHemOnc
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Update on ENESTop: TFR in CML after discontinuing nilotinib
    00:02:35

    Update on ENESTop: TFR in CML after discontinuing nilotinib

    127 Views
    1 year ago
    VJHemOnc
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Benefits of second generation TKIs for CML in the frontline
    00:01:45

    Benefits of second generation TKIs for CML in the frontline

    93 Views
    1 year ago
    VJHemOnc
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Personalized therapy in leukemia: a case study
    00:01:04

    Personalized therapy in leukemia: a case study

    237 Views
    1 year ago
    VJHemOnc
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    New drugs for CML: are more to come?
    00:00:37

    New drugs for CML: are more to come?

    65 Views
    1 year ago
    VJHemOnc
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login

    Colorectal Cancer

    Are These Gene Fusions Targetable? @katherineclift4 @WUSTL Are These Gene Fusions Targetable? @katherineclift4 @WUSTL
    0:02:35

    Are These Gene Fusions Targetable? @katherineclift4 @WUSTL

    3 Views
    1 month ago
    WUSTL
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Anti-EGFR Resistance Mechanism Using Tumor DNA Assay @katherineclift4 @WUSTL Anti-EGFR Resistance Mechanism Using Tumor DNA Assay @katherineclift4 @WUSTL
    0:07:15

    Anti-EGFR Resistance Mechanism Using Tumor DNA Assay @katherineclift4 @WUSTL

    23 Views
    1 month ago
    WUSTL
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    BEACON Trial: What's Next? BEACON Trial: What's Next?
    0:02:57

    BEACON Trial: What's Next?

    11 Views
    1 month ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Phase 3 BEACON CRC Trial Phase 3 BEACON CRC Trial
    0:04:43

    Phase 3 BEACON CRC Trial

    70 Views
    1 month ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...

    Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...

    29 Views
    2 months ago
    Cancer-News
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login
    How does this affect treatment? How does this affect treatment?
    0:01:40

    How does this affect treatment?

    10 Views
    2 months ago
    Cleveland Clinic
    Add to
    Want to watch this again later?
    Sign in to add this video to a playlist. Login